National Research Corporation
NRCNASDAQHealthcare● Active
$19.45
+$0.31(+1.62%)
Market Cap$438338815
P/E Ratio—
52W High$22.79
52W Low$11.014
National Research Corporation (NRC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NRC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.14B | $0.14B | $0.15B | $0.15B | $0.15B |
| Cost of Revenue | $0.06B | $0.06B | $0.06B | $0.06B | $0.05B |
| Gross Profit | $0.08B | $0.09B | $0.09B | $0.09B | $0.10B |
| Gross Margin %(computed) | 56.33% | 60.20% | 62.30% | 62.36% | 64.62% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.05B | $0.05B | $0.05B | $0.05B | $0.05B |
| Operating Income | $0.02B | $0.04B | $0.04B | $0.05B | $0.05B |
| Operating Margin %(computed) | 16.44% | 24.60% | 26.95% | 30.71% | 33.98% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.02B | $0.03B | $0.04B | $0.04B | $0.05B |
| Income Tax Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Net Income | $0.01B | $0.02B | $0.03B | $0.03B | $0.04B |
| Net Margin %(computed) | 8.44% | 17.32% | 20.84% | 20.98% | 25.32% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.52 | $1.05 | $1.26 | $1.28 | $1.47 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B |
| EBITDA | $0.03B | $0.04B | $0.05B | $0.05B | $0.06B |
| EBITDA Margin %(computed) | 22.00% | 28.87% | 30.95% | 32.53% | 38.30% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more National Research Corporation data
About National Research Corporation (NRC) Income Statement
National Research Corporation (NRC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NRC reported revenue of $0.14B, gross profit of $0.08B (gross margin 56.33%), and net income of $0.01B — a net profit margin of 8.44%.
Frequently asked questions
NRC · 4 questionsNational Research Corporation (NRC) reported revenue of $0.14B for 2025, down 4.0% year-over-year.
NRC revenueNRC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08